TILTAN PHARMA
One of the major advances in cancer research over the past decade has been the realization that tumor growth is dependent on the tumor's ability to recruit blood vessels from the neighboring tissue. Angiogenesis, the process by which new blood vessels are formed, is a hallmark capability of cancer, critical for the development of all solid tumors. This property is the basis for anti-angiogenic therapy, a promising novel strategy for treatment of cancer.
TILTAN PHARMA
Industry:
Biotechnology Health Care Therapeutics
Founded:
2006-01-01
Address:
Jerusalem, Yerushalayim, Israel
Country:
Israel
Website Url:
http://www.tiltanpharma.com
Total Employee:
1+
Status:
Active
Contact:
97286473836
Email Addresses:
[email protected]
Total Funding:
1.5 M USD
Technology used in webpage:
Apache Euro Google Apps For Business Typekit GoDaddy Starfield Technologies Adobe Muse Adobe Creative Cloud WebFonts
Current Employees Featured
Founder
Official Site Inspections
http://www.tiltanpharma.com Semrush global rank: 6.11 M Semrush visits lastest month: 1.33 K
- Host name: 67.89.153.160.host.secureserver.net
- IP address: 160.153.89.67
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Tiltan Pharma"
Tiltan Pharma - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 97286473836 One of the major advances in cancer research over the past decade has been the realization that tumor growth is โฆSee details»
Tiltan Pharma 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Tiltan Pharma. Use the PitchBook Platform to explore the full profile.See details»
Tiltan Pharma Company Profile | Management and Employees List
Www.tiltanpharma.com . Contact Information. Headquarters. 1 1 Hi Tech Village Edmond Safra Campus Givat Ram, Jerusalem, Jerusalem, Israel +972 2-566-9411. Tiltan Pharma Profile and โฆSee details»
Tiltan Pharma - Craft
Tiltan Pharma has 5 employees at their 1 location and $1.5 m in total funding,. See insights on Tiltan Pharma including office locations, competitors, revenue, financials, executives, โฆSee details»
Wegis & Young: Buttonwillow, California, USA
The Wegis and Young families have been an instrumental part of California and Kern County agriculture as well as the community for well over 100 years. Our operation was born at the โฆSee details»
Tiltan Pharma Overview | SignalHire Company Profile
Organization Website: tiltanpharma.com : Tiltan Pharma industries Biotech: Headquarters Location: 2-4 Hi-tech Village, Jerusalem, Jerusalem District, 91390 IL 2-4 Hi-tech Village, โฆSee details»
Tiltan Pharma - Israeli Startup | Startup Nation Finder
Mar 19, 2012 Tiltan Pharma is a biopharmaceutical company that developed a proprietary anti-angiogenic and immune modulatory platform for the treatment of cancer.See details»
Tiltan Pharma - Overview, News & Similar companies - ZoomInfo
View Tiltan Pharma (www.tiltanpharma.com) location in Jerusalem, Israel , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Tiltan Pharma - 2025 Company Profile - Tracxn
Feb 25, 2025 Tiltan Pharma - Develops therapeutics for treatment of metastatic pancreatic cancer using combinatorial drug therapy technology. This company is not active anymore. โฆSee details»
Tiltan Pharma - VentureRadar
Website: http://www.tiltanpharma.com/ Tiltan Pharmaโs proprietary anti-cancer platform is based on a combination of agents that target different, non-overlapping ...See details»
Tiltan Pharma Ltd. (Tiltan Pharma Ltd.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ โฆ
TL-118 is an anti-angiogenic drug combination designed for the treatment of cancer. The investigational product Tl-118 comprises of four well-known active components.See details»
Tiltan Pharma - Golden
Tiltan Pharma is an oncology company. Overview Structured Data Issues Contributors Activity. ContentsSee details»
Tiltan Pharma - Products, Competitors, Financials, Employees ...
Tiltan Pharma Raises $1.5 Million. Feb 5, 2014. Kunshan RiboQuark Raises .5 Million for siRNA Projects Tiltan Pharma Ltd. today announced that it has raised $1.5 million for the completion โฆSee details»
Tiltan Pharma CEO and Key Executive Team | Craft.co
Tiltan Pharma's Chief Operating Officer is Dan Goldstaub. Other executives include Osnat Ohne, Chief Operating Officer; Shmuel Rubinstein, Chairman, Former Chief Executive Officer and โฆSee details»
Tiltan Pharma Ltd.:Company Profile & Technical โฆ
Tiltan Pharma Ltd. is a company that provides Pharmacy and Therapeutics, Blood vessel, Cancer research and more. Tiltan Pharma Ltd. is headquartered in Israel .See details»
Tiltan Pharma | LinkedIn
Tiltan Pharma | ูฆูค ู ู ุงูู ุชุงุจุนูู ุนูู LinkedIn. Tiltan Pharma is a clinical stage biotechnology company focused on the development of novel and synergistic combinations of known drugs for the โฆSee details»
Tiltan Pharma Culture | Comparably
Learn about Tiltan Pharma's culture, see what work's like, read reviews, and find job opportunities.See details»
Tiltan Pharma Financial Overview, Employee Count, and Competitors
+972 2-566-9411. Jerusalem, Jerusalem District. tiltanpharma.comSee details»
Tiltan Pharma Raises $1.5 Million โ Integra Holdings
Jerusalem, Israel - February 5, 2014 - Tiltan Pharma Ltd. today announced that it has raised $1.5 million for the completion of its on-going Phase 2 clinical study of TL-118, an anti-angiogenic โฆSee details»
Novartis receives third FDA approval for oral Fabhalta® (iptacopan ...
5 days ago Novartis receives third FDA approval for oral Fabhalta ® (iptacopan) โ the first and only treatment approved in C3 glomerulopathy (C3G). Phase III study showed sustained โฆSee details»